According to the Minsheng Health announcement, as of July 31, 2026, the company had repurchased 2.32 million shares through centralized bidding transactions, accounting for 0.65% of the total share capital. The highest transaction price was 15.67 yuan/share, the lowest transaction price was 11.77 yuan/share, and the payment amount was 34.1525 million yuan. The company decided to implement the second phase of the share repurchase in October 2025 for equity incentives. It is expected to repurchase 2.1 million to 2.4 million shares, with capital not exceeding 505.44 million yuan. The implementation period is 12 months. In the future, the repurchase plan will continue to be implemented and disclosed in accordance with regulations.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.